title: Premedication with 20 mg dexamethasone effectively prevents relapse of extensive skin rash associated with gemcitabine monotherapy.
authors.forename: M
authors.initials: M
authors.lastname: Kanai
authors.forename: S
authors.initials: S
authors.lastname: Matsumoto
authors.forename: T
authors.initials: T
authors.lastname: Nishimura
authors.forename: Y
authors.initials: Y
authors.lastname: Matsumura
authors.forename: E
authors.initials: E
authors.lastname: Hatano
authors.forename: A
authors.initials: A
authors.lastname: Mori
authors.forename: T
authors.initials: T
authors.lastname: Masui
authors.forename: Y
authors.initials: Y
authors.lastname: Kawaguchi
authors.forename: E
authors.initials: E
authors.lastname: Nakamura
authors.forename: S
authors.initials: S
authors.lastname: Tada
authors.forename: T
authors.initials: T
authors.lastname: Kitano
authors.forename: H
authors.initials: H
authors.lastname: Ishiguro
authors.forename: K
authors.initials: K
authors.lastname: Yanagihara
authors.forename: T
authors.initials: T
authors.lastname: Chiba
mesh_terms: D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D003841:Deoxycytidine / Q000009:adverse effects / Q000031:analogs & derivatives*; D003907:Dexamethasone / Q000627:therapeutic use*; D005076:Exanthema / Q000139:chemically induced / Q000517:prevention & control*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010190:Pancreatic Neoplasms / Q000188:drug therapy; D011292:Premedication / Q000379:methods*; D055502:Secondary Prevention; D000093542:Gemcitabine
chemical_list: D000893:Anti-Inflammatory Agents; D000970:Antineoplastic Agents; D003841:Deoxycytidine; D003907:Dexamethasone; D000093542:Gemcitabine